The FDA has begun two proof-of-concept pilots to test real-time safety data monitoring and explore AI-assisted trial design, starting with oncology studies from AstraZeneca and Amgen. The initiative ...
The FDA has launched two proof-of-concept studies to test real-time safety data monitoring in cancer trials and is seeking input on a pilot program to integrate AI into early-phase trial design. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results